# Effectiveness and Safety of Artesunate-Amodiaquine and Artemether-Lumefantrine for the Treatment of Malaria in Yaounde

> **NCT04565184** · PHASE4 · COMPLETED · sponsor: **University of Yaounde 1** · enrollment: 242 (actual)

## Conditions studied

- Malaria,Falciparum

## Interventions

- **DRUG:** Artesunate-amodiaquine combination
- **DRUG:** Artemether, Lumefantrine Drug Combination

## Key facts

- **NCT ID:** NCT04565184
- **Lead sponsor:** University of Yaounde 1
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-05-09
- **Primary completion:** 2020-11-30
- **Final completion:** 2020-11-30
- **Target enrollment:** 242 (ACTUAL)
- **Last updated:** 2021-04-02

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04565184

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04565184, "Effectiveness and Safety of Artesunate-Amodiaquine and Artemether-Lumefantrine for the Treatment of Malaria in Yaounde". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04565184. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*